Grazyna Kochan

6PUBLICATIONS
22CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular imaging (incl. electron microscopy and neutron diffraction)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 19, 2024
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.

Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio

|Jan 10, 2024
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.

Ester Blanco, Noelia Silva-Pilipich, Ana Bocanegra

|Oct 04, 2023
Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer.

Virginia Arrazubi, Saioa Goñi, Iranzu González-Borja

|Jun 27, 2023
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer.

Ana Bocanegra, Gonzalo Fernández-Hinojal, Daniel Ajona

|Jul 06, 2019
Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy.

Miren Zuazo, Hugo Arasanz, Gonzalo Fernández-Hinojal

|Jan 18, 2018
Characterization of Macrophage Endogenous S-Nitrosoproteome Using a Cysteine-Specific Phosphonate Adaptable Tag in Combination with TiO<sub>2</sub> Chromatography.

María Ibáñez-Vea, Honggang Huang, Xabier Martínez de Morentin

Pageof 1

Frequent Collaborators

6 joint publications

David Escors

4 joint publications

Ruth Vera

4 joint publications

Ana Isabel Bocanegra

3 joint publications

Luisa Chocarro